{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:52:53Z","timestamp":1794585173227,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ymgme.2023.107734","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:02:29Z","timestamp":1699624949000},"page":"107734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Newborn screening for adrenoleukodystrophy: International experiences and challenges"],"prefix":"10.1016","volume":"140","author":[{"given":"Cecilie","family":"Videb\u00e6k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Melgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan M.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine Weller","family":"Gr\u00f8nborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107734_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107734_bb0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy \u2013 neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymgme.2023.107734_bb0015","author":"The ABCD1 Variant Database"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MED.0000000000000515","article-title":"Adrenoleukodystrophy in the era of newborn screening","volume":"27","author":"Eng","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107734_bb0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11910-014-0486-0","article-title":"X-linked Adrenoleukodystrophy: pathogenesis and treatment","volume":"14","author":"Engelen","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107734_bb0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/endrev\/bnaa013","article-title":"The changing face of adrenoleukodystrophy","volume":"41","author":"Zhu","year":"2020","journal-title":"Endocr. Rev."},{"issue":"24","key":"10.1016\/j.ymgme.2023.107734_bb0035","doi-asserted-by":"crossref","first-page":"e2499","DOI":"10.1212\/WNL.0000000000009626","article-title":"Clinical and radiographic course of arrested cerebral adrenoleukodystrophy","volume":"94","author":"Mallack","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ymgme.2023.107734_bb0040","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/cells10123427","article-title":"Molecular biomarkers for Adrenoleukodystrophy: an unmet need","volume":"10","author":"Honey","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.ymgme.2023.107734_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104781","article-title":"Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy","volume":"96","author":"Weinhofer","year":"2023","journal-title":"eBioMedicine."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107734_bb0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/cells11050913","article-title":"Evaluation of neurofilament light chain as a biomarker of neurodegeneration in X-linked childhood cerebral adrenoleukodystrophy","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0055","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","article-title":"Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy","volume":"12","author":"Weinhofer","year":"2021","journal-title":"Nat. Commun."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2023.107734_bb0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awt361","article-title":"X-linked adrenoleukodystrophy in women: a cross-sectional cohort study","volume":"137","author":"Engelen","year":"2014","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-019-1008-6","article-title":"Disease progression in women with X-linked adrenoleukodystrophy is slow","volume":"14","author":"Huffnagel","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2023.107734_bb0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/14712598.2022.2124857","article-title":"Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy","volume":"22","author":"Gupta","year":"2022","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ymgme.2023.107734_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201374","article-title":"International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: a consensus-based approach","author":"Engelen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107734_bb0080","author":"Research C for BE and SKYSONA"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107734_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2009.03.010","article-title":"Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS\/MS) method","volume":"97","author":"Hubbard","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107734_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2006.05.001","article-title":"Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings","volume":"89","author":"Hubbard","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymgme.2014.11.013","article-title":"Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy","volume":"114","author":"Turgeon","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107734_bb0105","article-title":"High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan","volume":"32","author":"Chen","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107734_bb0110","article-title":"Sex-specific newborn screening for X-linked adrenoleukodystrophy","author":"Albersen","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107734_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ijns7030058","article-title":"Advanced diagnostic system and introduction of newborn screening of Adrenoleukodystrophy and Peroxisomal disorders in Japan","volume":"7","author":"Shimozawa","year":"2021","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2023.107734_bb0120","doi-asserted-by":"crossref","first-page":"1072256","DOI":"10.3389\/fneur.2022.1072256","article-title":"Newborn screening for X-linked adrenoleukodystrophy in Italy: diagnostic algorithm and disease monitoring","volume":"13","author":"Bonaventura","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2023.107734_bb0125","series-title":"Principles and Practice of Screening for Disease","volume":"168","author":"Wilson","year":"2023"},{"issue":"14","key":"10.1016\/j.ymgme.2023.107734_bb0130","doi-asserted-by":"crossref","first-page":"E422","DOI":"10.1503\/cmaj.171154","article-title":"Consolidated principles for screening based on a systematic review and consensus process","volume":"190","author":"Dobrow","year":"2018","journal-title":"Can. Med. Assoc. J."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107734_bb0135","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ajmg.a.63144","article-title":"Neonatal lupus is a novel cause of positive newborn screening for X-linked adrenoleukodystrophy","volume":"191","author":"Niehaus","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2023.107734_bb0140","doi-asserted-by":"crossref","first-page":"107678","DOI":"10.1016\/j.ymgme.2023.107678","article-title":"VUS: Variant of uncertain significance or very unclear situation?","author":"Kemp","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107734_bb0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/cells11020283","article-title":"Structure and function of the ABCD1 variant database: 20 years, 940 pathogenic variants, and 3400 cases of adrenoleukodystrophy","volume":"11","author":"Mallack","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ymgme.2023.107734_bb0150","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3390\/genes12121930","article-title":"Biochemical studies in fibroblasts to interpret variants of unknown significance in the ABCD1 gene","volume":"12","author":"van de Stadt","year":"2021","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107734_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/ijns6030062","article-title":"The clinical impact of CLIR tools toward rapid resolution of post-newborn screening confirmatory testing for X-linked adrenoleukodystrophy in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107734_bb0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ajmg.a.61171","article-title":"A report on state-wide implementation of newborn screening for X-linked adrenoleukodystrophy","volume":"179","author":"Wiens","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2023.107734_bb0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fcell.2020.00499","article-title":"Adrenoleukodystrophy newborn screening in the Netherlands (SCAN study): The X-factor","volume":"8","author":"Barendsen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107734_bb0170","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.3390\/ijns6040081","article-title":"Newborn screening for X-linked adrenoleukodystrophy in Georgia: experiences from a pilot study screening of 51,081 newborns","volume":"6","author":"Hall","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20356","article-title":"Evaluation of X-linked Adrenoleukodystrophy newborn screening in North Carolina","volume":"3","author":"Lee","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107734_bb0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijns7020022","article-title":"Adrenoleukodystrophy newborn screening in California since 2016: programmatic outcomes and follow-up","volume":"7","author":"Matteson","year":"2021","journal-title":"Int. J. Neonatal. Screen."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107734_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/ijns8020029","article-title":"Newborn screening for X-linked Adrenoleukodystrophy in Nebraska: initial experiences and challenges","volume":"8","author":"Baker","year":"2022","journal-title":"Int. J. Neonatal. Screen."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107734_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijns8020024","article-title":"Newborn screening for X-linked adrenoleukodystrophy: review of data and outcomes in Pennsylvania","volume":"8","author":"Priestley","year":"2022","journal-title":"Int. J. Neonatal. Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijns8010006","article-title":"Newborn screening for X-linked Adrenoleukodystrophy: The initial Illinois experience","volume":"8","author":"Burton","year":"2022","journal-title":"Int. J. Neonatal. Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0200","first-page":"121","article-title":"Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation","volume":"19","author":"Kemper","year":"2017","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107734_bb0205","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","article-title":"Newborn screening for X-linked adrenoleukodystrophy in New York state: diagnostic protocol, surveillance protocol and treatment guidelines","volume":"114","author":"Vogel","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107734_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ijns8040051","article-title":"Newborn screening is on a collision course with public health ethics","volume":"8","author":"Currier","year":"2022","journal-title":"Int. J. Neonatal. Screen."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107734_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ijns9030051","article-title":"Attitudes of patients with Adrenoleukodystrophy towards sex-specific newborn screening","volume":"9","author":"Yska","year":"2023","journal-title":"Int. J. Neonatal. Screen."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107734_bb0225","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1089\/gte.2007.0001","article-title":"Attitudes of families affected by adrenoleukodystrophy toward prenatal diagnosis, presymptomatic and carrier testing, and newborn screening","volume":"11","author":"Schaller","year":"2007","journal-title":"Genet. Test."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107734_bb0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ijns5040042","article-title":"Family perspectives on newborn screening for X-linked Adrenoleukodystrophy in California","volume":"5","author":"Schwan","year":"2019","journal-title":"Int. J. Neonatal. Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107734_bb0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-018-0921-4","article-title":"Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme","volume":"13","author":"Bessey","year":"2018","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T12:15:24Z","timestamp":1735215324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223003645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1096719223003645"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107734","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newborn screening for adrenoleukodystrophy: International experiences and challenges","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107734"}}